Patents Assigned to Humanetics Corporation
  • SUSPENSION COMPOSITIONS OF PHYSIOLOGICALLY ACTIVE PHENOLIC COMPOUNDS & METHODS OF MAKING AND USING THE SAME
    Publication number: 20160279093
    Abstract: The present invention is directed to compositions comprising physiologically active phenolic compounds and methods for making and using the same. In particular embodiments, the compositions described herein include suspension formulations including a physiologically active phenolic compound provided as a nanoparticulate material and dispersed within an edible lipid.
    Type: Application
    Filed: June 3, 2016
    Publication date: September 29, 2016
    Applicant: Humanetics Corporation
    Inventors: David C. Egberg, Michael D. Kaytor, John C. Dykstra
  • Suspension compositions of physiologically active phenolic compounds and methods of making and using the same
    Patent number: 9387171
    Abstract: The present invention is directed to compositions comprising physiologically active phenolic compounds and methods for making and using the same. In particular embodiments, the compositions described herein include suspension formulations including a physiologically active phenolic compound provided as a nanoparticulate material and dispersed within an edible lipid.
    Type: Grant
    Filed: June 15, 2015
    Date of Patent: July 12, 2016
    Assignee: Humanetics Corporation
    Inventors: David C. Egberg, Michael D. Kaytor, John C. Dykstra
  • NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME
    Publication number: 20160175276
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Application
    Filed: March 1, 2016
    Publication date: June 23, 2016
    Applicant: Humanetics Corporation
    Inventors: Edmund Joseph Elder, JR., Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • Nanoparticle isoflavone compositions and methods of making and using the same
    Patent number: 9308167
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Grant
    Filed: October 27, 2014
    Date of Patent: April 12, 2016
    Assignee: Humanetics Corporation
    Inventors: Edmund Joseph Elder, Jr., Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • SUSPENSION COMPOSITIONS OF PHYSIOLOGICALLY ACTIVE PHENOLIC COMPOUNDS & METHODS OF MAKING AND USING THE SAME
    Publication number: 20150272887
    Abstract: The present invention is directed to compositions comprising physiologically active phenolic compounds and methods for making and using the same. In particular embodiments, the compositions described herein include suspension formulations including a physiologically active phenolic compound provided as a nanoparticulate material and dispersed within an edible lipid.
    Type: Application
    Filed: June 15, 2015
    Publication date: October 1, 2015
    Applicant: Humanetics Corporation
    Inventors: David C. Egberg, Michael D. Kaytor, John C. Dykstra
  • Suspension compositions of physiologically active phenolic compounds and methods of making and using the same
    Patent number: 9084726
    Abstract: The present invention is directed to compositions comprising physiologically active phenolic compounds and methods for making and using the same. In particular embodiments, the compositions described herein include suspension formulations including a physiologically active phenolic compound provided as a nanoparticulate material and dispersed within an edible lipid.
    Type: Grant
    Filed: November 26, 2013
    Date of Patent: July 21, 2015
    Assignee: Humanetics Corporation
    Inventors: David C. Egberg, Michael D. Kaytor, John C. Dykstra
  • SUSPENSION COMPOSITIONS OF PHYSIOLOGICALLY ACTIVE PHENOLIC COMPOUNDS & METHODS OF MAKING AND USING THE SAME
    Publication number: 20150147359
    Abstract: The present invention is directed to compositions comprising physiologically active phenolic compounds and methods for making and using the same. In particular embodiments, the compositions described herein include suspension formulations including a physiologically active phenolic compound provided as a nanoparticulate material and dispersed within an edible lipid.
    Type: Application
    Filed: November 26, 2013
    Publication date: May 28, 2015
    Applicant: Humanetics Corporation
    Inventors: David C. Egberg, Michael D. Kaytor, John C. Dykstra
  • NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME
    Publication number: 20150050357
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Application
    Filed: October 27, 2014
    Publication date: February 19, 2015
    Applicant: Humanetics Corporation
    Inventors: Edmund Joseph Elder, JR., Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • Nanoparticle isoflavone compositions and methods of making and using the same
    Patent number: 8900635
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Grant
    Filed: November 15, 2010
    Date of Patent: December 2, 2014
    Assignee: Humanetics Corporation
    Inventors: Edmund Joseph Elder, Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • Nanoparticle isoflavone compositions and methods of making and using the same
    Patent number: 8551530
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: October 8, 2013
    Assignee: Humanetics Corporation
    Inventors: Edmund Joseph Elder, Jr., Mark Joseph Sacchetti, Randall Joseph Tiachac, John L. Zenk
  • NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME
    Publication number: 20120164190
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Application
    Filed: March 2, 2012
    Publication date: June 28, 2012
    Applicant: Humanetics Corporation
    Inventors: Edmund Joseph Elder, Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • NANOPARTICLE ISOFLAVONE COMPOSITIONS & METHODS OF MAKING AND USING THE SAME
    Publication number: 20120121654
    Abstract: The present invention is directed to formulations of genistein and methods for making and using the same. In particular embodiments, the formulations described herein include suspension formulations of nanoparticulate genistein.
    Type: Application
    Filed: November 15, 2010
    Publication date: May 17, 2012
    Applicant: HUMANETICS CORPORATION
    Inventors: Edmund Joseph Elder, JR., Mark Joseph Sacchetti, Randall Joseph Tlachac, John L. Zenk
  • Treatment of chronic fatigue syndrome and fibromyalgia syndrome
    Patent number: 7553829
    Abstract: Chronic fatigue syndrome (CFS) and fibromyalgia syndrome (FMS) can be treated by the administration of ?5-androstene-3?-ol-7,17 dione and metabolizable precursors thereof.
    Type: Grant
    Filed: October 31, 2001
    Date of Patent: June 30, 2009
    Assignee: Humanetics Corporation
    Inventors: Ronald J. Zenk, John L. Zenk
  • Method of modulating the basal metabolic rate of a dieting mammal by administration of a metabolic modulating agent to the dieting mammal
    Patent number: 7199116
    Abstract: Modulating the metabolism of a dieting mammal by administering to the dieting mammal the metabolic modulating agent 7-oxo DHEA or a pro-drug thereof incapable of in vivo conversion to testosterone.
    Type: Grant
    Filed: January 13, 2003
    Date of Patent: April 3, 2007
    Assignee: Humanetics Corporation
    Inventor: John Zenk
  • Method of achieving accelerated fat loss by administration of a fat loss accelerating agent to a dieting mammal
    Publication number: 20060217357
    Abstract: Accelerating fat loss by administering to a dieting mammal the fat loss accelerating agent 7-oxo DHEA or a pro-drug thereof incapable of in vivo conversion to testosterone.
    Type: Application
    Filed: January 12, 2004
    Publication date: September 28, 2006
    Applicant: HUMANETICS CORPORATION
    Inventor: John Zenk
  • Use of &Dgr;5-androstene-3&bgr;-OL7,17-dione in the treatment of arthritis
    Patent number: 6794374
    Abstract: Arthritis can be treated by administering therapeutic amounts of &Dgr;5-androstene-3&bgr;-ol-7,17-dione and metabolizable precursors thereof, such a &Dgr;5-androstene-3&bgr;-acetoxy-7,17-dione, which are readily metabolized in vivo to &Dgr;5-androstene-3&bgr;-ol-7,17-dione but are not appreciably metabolizable in vivo to androgens, estrogens or dehydroepiandrosterone. Such treatment can be prophylactic, ameliorative or curative in nature.
    Type: Grant
    Filed: November 27, 2000
    Date of Patent: September 21, 2004
    Assignee: Humanetics Corporation
    Inventor: Charles E. Weeks
  • Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
    Patent number: 6770280
    Abstract: Treatment of menorrhagia, hypermenorrhea and dysmenorrhea by the administration of a therapeutic amount of an antibacterial milk product.
    Type: Grant
    Filed: November 15, 2001
    Date of Patent: August 3, 2004
    Assignee: Humanetics Corporation
    Inventor: Dale R. Henn
  • Memory by the administration of &Dgr;5-androstene-3&bgr;-ol-7,17-dione and 3&bgr; esters
    Patent number: 6489313
    Abstract: The memory of a healthy mammal and the memory of a mammal with age impaired memory can be improved by administering an effective amount of &Dgr;5-Androstene-3&bgr;-ol-7,17-dione and 3&bgr; esters thereof.
    Type: Grant
    Filed: November 1, 2000
    Date of Patent: December 3, 2002
    Assignee: Humanetics Corporation
    Inventors: Henry A. Lardy, Jennifer Y. Shi
  • Method of moisturizing the skin by the topical application of &Dgr;5-androstene-3&bgr;-ol-7,17 dione and metabolizable precursors thereof
    Patent number: 6399085
    Abstract: Human skin can be moisturized by the administration of &Dgr;5-androstene-3&bgr;-ol-7,17 dione and metabolizable precursors thereof, such as &Dgr;5-androstene-3&bgr;-acetoxy-7,17 dione.
    Type: Grant
    Filed: March 5, 2001
    Date of Patent: June 4, 2002
    Assignee: Humanetics Corporation
    Inventors: Ronald J. Zenk, John L. Zenk
  • Method for diminishing wrinkles and fine lines of the skin by the topical application of &Dgr;5-androstene-3&bgr;-ol-7, 17 dione and metabolizable precursors thereof
    Patent number: 6399084
    Abstract: Wrinkles and fine lines occurring on human skin can be diminished by the administration of &Dgr;5-androstene-3&bgr;-ol-7,17 dione and metabolizable precursors thereof, such as &Dgr;5-androstene-3&bgr;-acetoxy-7,17 dione, to the skin.
    Type: Grant
    Filed: March 5, 2001
    Date of Patent: June 4, 2002
    Assignee: Humanetics Corporation
    Inventors: Ronald J. Zenk, John L. Zenk